BR9911160A - Ciclosporinas - Google Patents

Ciclosporinas

Info

Publication number
BR9911160A
BR9911160A BR9911160-8A BR9911160A BR9911160A BR 9911160 A BR9911160 A BR 9911160A BR 9911160 A BR9911160 A BR 9911160A BR 9911160 A BR9911160 A BR 9911160A
Authority
BR
Brazil
Prior art keywords
cyclosporins
letters
report
compounds
processes
Prior art date
Application number
BR9911160-8A
Other languages
English (en)
Inventor
Ernst Ellmerer-Mueller
Dagmar Broessner
Najib Maslouh
Horst-Dieter Ambrosi
Gerhard Jas
Gunter Fischer
Original Assignee
Chem Ag C
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chem Ag C filed Critical Chem Ag C
Publication of BR9911160A publication Critical patent/BR9911160A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • C07K7/645—Cyclosporins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Cardiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Patente de Invenção: <B>"CICLOSPORINAS"<D>. Compostos da fórmula (I) e seus sais farmaceuticamente aceitáveis onde as letras A a L têm o significado indicado no relatório e processos para a sua preparação e seus usos.
BR9911160-8A 1998-06-12 1999-06-10 Ciclosporinas BR9911160A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98110761 1998-06-12
PCT/EP1999/004012 WO1999065933A1 (en) 1998-06-12 1999-06-10 Novel cyclosporins

Publications (1)

Publication Number Publication Date
BR9911160A true BR9911160A (pt) 2001-04-03

Family

ID=8232110

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9911160-8A BR9911160A (pt) 1998-06-12 1999-06-10 Ciclosporinas

Country Status (19)

Country Link
US (1) US6583265B1 (pt)
EP (1) EP1086124B1 (pt)
JP (1) JP4477777B2 (pt)
KR (1) KR20010052766A (pt)
CN (1) CN1205220C (pt)
AT (1) ATE254630T1 (pt)
AU (1) AU760168B2 (pt)
BR (1) BR9911160A (pt)
CA (1) CA2334730C (pt)
DE (1) DE69912952T2 (pt)
DK (1) DK1086124T3 (pt)
ES (1) ES2212583T3 (pt)
HU (1) HUP0102833A3 (pt)
IL (1) IL139825A0 (pt)
MX (1) MXPA00012218A (pt)
NO (1) NO20006282L (pt)
PL (1) PL344599A1 (pt)
PT (1) PT1086124E (pt)
WO (1) WO1999065933A1 (pt)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1267903A4 (en) * 2000-02-08 2003-08-06 Pharmacia Corp METHODS OF TREATING GLAUCOMA
US6784156B2 (en) 2001-03-05 2004-08-31 Enanta Pharmaceuticals, Inc. Cyclosporins for the treatment of respiratory diseases
KR100465012B1 (ko) * 2001-05-11 2005-01-13 주식회사 엘지생활건강 모발 성장 효과를 갖는 사이클로스포린 3 위치 유도체를유효성분으로 하는 모발 성장 촉진제
US20030087813A1 (en) 2001-10-12 2003-05-08 Or Yat Sun Cyclosporin analogs for the treatment of lung diseases
KR20040039622A (ko) * 2002-11-04 2004-05-12 주식회사 엘지생활건강 모발 성장 효과를 갖는 사이클로스포린 3 위치 유도체를유효성분으로 하는 모발 성장 촉진제
US7012065B2 (en) 2003-02-07 2006-03-14 Enanta Pharmaceuticals, Inc. Cyclosporins for the treatment of immune disorders
KR20070009674A (ko) * 2004-04-08 2007-01-18 노파르티스 아게 대뇌 허혈 및 뇌와 척수 상해에서의 ｎｉｍ８１１
NZ554514A (en) * 2004-10-01 2010-10-29 Scynexis Inc 3-ether and 3-thioether substituted cyclosporin derivatives for the treatment and prevention of hepatitis C infection
US7196161B2 (en) 2004-10-01 2007-03-27 Scynexis Inc. 3-ether and 3-thioether substituted cyclosporin derivatives for the treatment and prevention of hepatitis C infection
NZ567262A (en) * 2005-09-30 2011-12-22 Scynexis Inc Cyclosporin derivatives and their use for the treatment and prevention of hepatitis C infection
ATE498630T1 (de) * 2005-09-30 2011-03-15 Scynexis Inc Arylalkyl- und heteroarylalkyl-derivate von cyclosporin a bei der behandlung und vorbeugung einer virusinfektion
WO2007136759A2 (en) * 2006-05-19 2007-11-29 Scynexis, Inc. Method for the treatment and prevention of ocular disorders
EP2027761A1 (fr) * 2006-06-02 2009-02-25 Claude Annie Perrichon Gestion des electrons actifs
US7576057B2 (en) 2006-11-20 2009-08-18 Scynexis, Inc. Cyclic peptides
WO2008127613A1 (en) * 2007-04-11 2008-10-23 Scynexis, Inc. New pharmaceutical compositions
WO2009148615A1 (en) * 2008-06-06 2009-12-10 Scynexis, Inc. Cyclosporin analogs and their use in the treatment of hcv infections
US9090671B2 (en) 2008-06-06 2015-07-28 Scynexis, Inc. Macrocyclic peptides
EP2313157A2 (en) 2008-07-10 2011-04-27 Allergan, Inc. Cyclosporin derivatives for treating ocular and dermal diseases and conditions
EP2376524B1 (en) 2008-12-31 2017-03-15 Cypralis Limited Derivatives of cyclosporin a
CA2763207A1 (en) * 2009-05-27 2010-12-02 Allergan, Inc. Cyclosporin derivatives for treating inflammatory diseases and conditions
WO2010138422A1 (en) * 2009-05-27 2010-12-02 Allergan, Inc. Cyclosporin derivatives for enhancing the growth of hair
CA2785978A1 (en) 2009-12-30 2011-07-07 Scynexis, Inc. Cyclosporine analogues
WO2012009715A2 (en) 2010-07-16 2012-01-19 S&T Global Inc. Novel cyclosporin derivatives for the treatment and prevention of a viral infection
CN103153330B (zh) 2010-08-12 2017-08-18 美国科技环球有限公司 新的环孢霉素衍生物在病毒感染的治疗和预防中的应用
AU2011316689B2 (en) * 2010-10-12 2016-07-14 Allergan, Inc. Cyclosporin analogs
BR112013008864A2 (pt) * 2010-10-12 2016-06-28 Allergan Inc análogos d ciclosporina
US9890198B2 (en) 2010-12-03 2018-02-13 S&T Global Inc. Cyclosporin derivatives and uses thereof
EP3461835A1 (en) 2010-12-15 2019-04-03 ContraVir Pharmaceuticals, Inc. Cyclosporine analogue molecules modified at amino acid 1 and 3
GB201711749D0 (en) * 2017-07-21 2017-09-06 Cypralis Ltd Cyclosporin analogues and uses thereof
CN111449050A (zh) * 2019-01-20 2020-07-28 睿诺医疗科技（上海）有限公司 环孢菌素类似物及其用途
CA3152922A1 (en) * 2019-10-12 2021-04-15 Michael Peel Treatment and prevention of nephrotoxin-induced kidney injuries
KR20230002589A (ko) * 2020-04-15 2023-01-05 파사이트 메디컬 테크놀로지 (상하이) 컴퍼니 리미티드 장기 손상의 예방 및 치료
GB202207348D0 (en) 2022-05-19 2022-07-06 Cypralis Ltd Macrocyclic compounds and uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0194972B1 (en) * 1985-03-11 1992-07-29 Sandoz Ag Novel cyclosporins
EP0842191B1 (de) 1995-07-17 2001-11-21 C-Chem AG Cyclosporin-derivate mit anti-hiv-wirkung
FR2757522B1 (fr) * 1996-12-24 1999-01-29 Rhone Poulenc Rorer Sa Derives de cyclosporine, leur preparation et les compositions pharmaceutiques qui les contiennent
FR2757520B1 (fr) * 1996-12-24 1999-01-29 Rhone Poulenc Rorer Sa Derive de cyclosporine, sa preparation et les compositions pharmaceutiques qui le contiennent
FR2757521B1 (fr) * 1996-12-24 1999-01-29 Rhone Poulenc Rorer Sa Nouveaux derives de cyclosporine, leur preparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
JP2002518406A (ja) 2002-06-25
PL344599A1 (en) 2001-11-05
NO20006282D0 (no) 2000-12-11
PT1086124E (pt) 2004-04-30
CN1205220C (zh) 2005-06-08
CA2334730C (en) 2009-09-29
DE69912952T2 (de) 2004-09-02
HUP0102833A3 (en) 2002-03-28
JP4477777B2 (ja) 2010-06-09
HUP0102833A2 (hu) 2002-01-28
CA2334730A1 (en) 1999-12-23
CN1305493A (zh) 2001-07-25
EP1086124B1 (en) 2003-11-19
ES2212583T3 (es) 2004-07-16
WO1999065933A1 (en) 1999-12-23
KR20010052766A (ko) 2001-06-25
US6583265B1 (en) 2003-06-24
MXPA00012218A (es) 2002-04-24
DK1086124T3 (da) 2004-03-29
DE69912952D1 (en) 2003-12-24
AU760168B2 (en) 2003-05-08
NO20006282L (no) 2001-02-12
ATE254630T1 (de) 2003-12-15
EP1086124A1 (en) 2001-03-28
IL139825A0 (en) 2002-02-10
AU4899399A (en) 2000-01-05

Similar Documents

Publication Publication Date Title
BR9911160A (pt) Ciclosporinas
BR9713363A (pt) Epotilonas c, d, e e f, preparação e composições
SE9504661D0 (sv) New compounds
LU90856I2 (fr) Uprima - apomorphine hydrochloride et ses d-riv-s pharmaceutiquement acceptables
BR0109272A (pt) Agentes conjugados terapêuticos de ácido poliglutâmico, métodos para suas preparações e usos
BR0108893A (pt) Composição farmacêutica, composto e processo de preparação de compostos
DK0733046T3 (da) Benzoylguanidiner, deres fremstilling og anvendelse i medikamenter
BR9901491A (pt) 7-hetero-biciclo [2.2.1] - heptanos.
TR200200579T2 (tr) Amino-tirazolpiridin türevleri.
AP2002002637A0 (en) Novel piperazine
HUP9802221A2 (hu) Parazitaellenes hatású markfortin- és paraherkvamidszármazékok
BR9712321A (pt) Aminotiofenocarboxamidas
BR0210507A (pt) Azaindóis
BR0007294A (pt) Formulações farmacêuticas aperfeiçoadas
SE9802208D0 (sv) Novel compounds
BR9912299A (pt) Derivados de bifenila
BR9905089A (pt) Derivados macrolìdeos
IS5851A (is) Ný lyf til inntöku 5-HT4 gerandefna eða mótlyfja
BR9916887A (pt) Uso de derivados de pirimidina
FI972434A (fi) Lamotrigiiniä sisältävä farmaseuttinen koostumus
DK0866791T3 (da) Diaminopyrimidiner, farmaceutiske præparater indeholdende disse og deres anvendelse som antibakterielle midler
BR0012169A (pt) Dihidrobenzodiazepinas e seu uso no tratamento de dislipidemia
DE69819539D1 (de) Antithrombotische mittel
BR9915692A (pt) Monohidrato de bromidrato de eletriptano
DE69921486D1 (de) Dextran-leptin konjugate, pharmazeutische zusammentsetzungen und verbundene verfahren

Legal Events

Date Code Title Description
FA10 Dismissal: dismissal - article 33 of industrial property law
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]